Correlation Between Israel Opportunity and XTL Biopharmaceutica
Can any of the company-specific risk be diversified away by investing in both Israel Opportunity and XTL Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Israel Opportunity and XTL Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Israel Opportunity and XTL Biopharmaceuticals, you can compare the effects of market volatilities on Israel Opportunity and XTL Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Israel Opportunity with a short position of XTL Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Israel Opportunity and XTL Biopharmaceutica.
Diversification Opportunities for Israel Opportunity and XTL Biopharmaceutica
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Israel and XTL is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Israel Opportunity and XTL Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XTL Biopharmaceuticals and Israel Opportunity is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Israel Opportunity are associated (or correlated) with XTL Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XTL Biopharmaceuticals has no effect on the direction of Israel Opportunity i.e., Israel Opportunity and XTL Biopharmaceutica go up and down completely randomly.
Pair Corralation between Israel Opportunity and XTL Biopharmaceutica
Assuming the 90 days trading horizon Israel Opportunity is expected to generate 8.54 times less return on investment than XTL Biopharmaceutica. But when comparing it to its historical volatility, Israel Opportunity is 4.28 times less risky than XTL Biopharmaceutica. It trades about 0.04 of its potential returns per unit of risk. XTL Biopharmaceuticals is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 330.00 in XTL Biopharmaceuticals on August 25, 2024 and sell it today you would earn a total of 340.00 from holding XTL Biopharmaceuticals or generate 103.03% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Israel Opportunity vs. XTL Biopharmaceuticals
Performance |
| Timeline |
| Israel Opportunity |
| XTL Biopharmaceuticals |
Israel Opportunity and XTL Biopharmaceutica Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Israel Opportunity and XTL Biopharmaceutica
The main advantage of trading using opposite Israel Opportunity and XTL Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Israel Opportunity position performs unexpectedly, XTL Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XTL Biopharmaceutica will offset losses from the drop in XTL Biopharmaceutica's long position.| Israel Opportunity vs. OPC Energy | Israel Opportunity vs. Delek Group | Israel Opportunity vs. Lapidoth | Israel Opportunity vs. Naphtha |
| XTL Biopharmaceutica vs. Nice | XTL Biopharmaceutica vs. The Gold Bond | XTL Biopharmaceutica vs. Bank Leumi Le Israel | XTL Biopharmaceutica vs. ICL Israel Chemicals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |